Is Your Life Sciences Patent Enabled? The U.S. Supreme Court Is Considering That Question

Procopio Perspectives
28/03/2023 23 min Episodio 14
Is Your Life Sciences Patent Enabled? The U.S. Supreme Court Is Considering That Question

Listen "Is Your Life Sciences Patent Enabled? The U.S. Supreme Court Is Considering That Question"

Descargar episodio Ver en sitio original

Episode Synopsis

Presenters:Jeff Morton, PhD, Procopio IP Partner and Life Sciences sector leader (San Diego)Robert "Bob" Sloss, Procopio IP Litigation Partner (Palo Alto)Jeremy Edwards, Procopio IP Litigation Partner (Washington, D.C.)

More episodes of the podcast Procopio Perspectives

Patent Considerations in View of the Nearshoring Trends to the Americas 20/09/2024
Advanced Clean Fleets: Part 2, High Priority and Federal Fleets 31/10/2023
Navigating California's Green Roadmap: Unpacking the 2024 Zero Emission Fleet Mandate 22/09/2023
The Dutch Route: Using the Netherlands to Build a Cost-effective Global Patent Portfolio 29/06/2023
What You Need to Know About the Unified Patent Court and Unitary Patent 08/05/2023
Grace Period Considerations in Australia, Japan, South East Asia and US 21/02/2023
Greater Speed and Efficiency: Steps IP Offices Around the World Are Taking to Streamline the Patent Process 19/12/2022
CCPA 2.0: What Companies Need to Know About the CPRA and Expiring Exemptions for Employee-Related and Business to Business Data 07/11/2022
Vietnam and Patent Protection – Observations, Developments and Strategies 13/07/2022
The Conundrum of CPRA's Exemption and California Employment Laws 23/03/2022
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA